Effect of RelB-silenced BMDC pulsed with Tα146-162 on immunoreaction of T cells primed with TAChR

Journal of Central South University (Medical Sciences)

Volumn 35, Issue 1, 2010, Pages 38-44

  Zhang, Yong ^a   Yang, Huan ^a   Xiao, Bo ^a   Lu, Tefei ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Dendritic cell; Lentiviral vector; Myasthenia gravis; RelB; RNA interference

Indexed keywords

NICOTINIC RECEPTOR; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN; RELB PROTEIN, MOUSE; SMALL INTERFERING RNA; TORPEDO ACETYLCHOLINE RECEPTOR, ALPHA SUBUNIT 1 20; TORPEDO ACETYLCHOLINE RECEPTOR, ALPHA-SUBUNIT 1-20; TRANSCRIPTION FACTOR RELB;

ANIMAL; ARTICLE; BONE MARROW CELL; C57BL MOUSE; DENDRITIC CELL; FEMALE; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LENTIVIRINAE; METABOLISM; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; RNA INTERFERENCE; T LYMPHOCYTE;

ANIMALS; BASE SEQUENCE; BONE MARROW CELLS; DENDRITIC CELLS; FEMALE; IMMUNE TOLERANCE; LENTIVIRUS; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RECEPTORS, NICOTINIC; RECOMBINANT PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; T-LYMPHOCYTES; TRANSCRIPTION FACTOR RELB;

EID: 77349126070     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1672-7347.2010.01.006     Document Type: Article

References (12)

1. Conti-Fine B M, Milani M, Kaminski H J. Myastheaia gravis : past, present, and future [J]. J Clin Invest, 2006, 116(11):2843-2854.
2. Gil-Torregrosa B C, Lennon-Dumenil A M, Kessler B, et al. Control of cross-presentation during dendritic cell maturation [J]. Eur J Immunol, 2004, 34(2):398-407.
3. Martin E, O' Sullivan B, Low P, et al. Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10[J]. Immunity, 2003, 18(1):155-167.
4. Min W P, Gorczynski R, Huang X Y, et al. Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival [J]. J Immunol, 2000, 164(1):161-167.
5. Livak K J, Schmittgen T D. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C(T)) Method [J]. Methods, 2001, 25 (4):402-408.
6. Cools N, Ponsaerts P, Van Tendeloo V F, et al. Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells [J]. J Leukoc Biol, 2007, 82(6):1365-1374.
7. Moore F, Buonocore S, Aksoy E, et al. An alternative pathway of NF-κB activation results in maturation and T cell priming activity of dendritic cells overexpressing a mutated IκBα[J]. J Immunol, 2007, 178(3):1301-1311.
8. MacDonald K P, Kuns R D, Rowe V, et al. Effector and regulatory T-cell function is differentially regulated by RelB within antigen-presenting cells during GVHD [J]. Blood, 2007, 109(11):5049-5057.
9. -/- BALB/c mice suggests a pathogenic role of Th1 Cells [J]. J Immunol, 2004, 172(1):97-103.
10. Ichim T E, Li M, Qian H, et al. RNA interference: a potent tool for gene-specific therapeutics [J]. Am J Transplant, 2004, 4(8):1227-1236.
11. Ageichik A, Collins M K, Dewannieux M. Lentivector targeting to dendritic cells [J]. Mol Ther, 2008, 16(6): 1008-1009.
12. Bastos K R, de Deus Vieira de Moraes L, Zago C A, et al. Analysis of the activation profile of dendritic cells derived from the bone marrow of interleukin-12/interleukin-23-deficient mice [J]. Immunology, 2005, 114(4):499-506.